ZeST platform subscription - Organisation

Normaler Preis €3.160,85 EUR exc. VAT
Normaler Preis exc. VAT Verkaufspreis €3.160,85 EUR exc. VAT
inkl. MwSt. Versand wird beim Checkout berechnet

ZeST is a browser-based, serious game learning platform

Unlock full access to the entire ZeST online game library for your organisation for 12 months.

ZeST is a web-based team learning and serious games platform designed to enhance engagement, training and discussion across groups, whether online (over TEAMS / ZOOM) or in person. Its evidence-based games work on any device and are ideal for staff development, team building and competency training.

How ZeST works - https://zestfocus.com/images/how-to-use.mp4

This unlimited-access licence:
Grants your organisation unrestricted access to every ZeST online team game for 12 months.
Removes the need to purchase individual game licences one by one (each of which normally covers a single game for 12 months).
Allows you to host unlimited sessions with any number of participants — perfect for group training, workshops and organisational learning.


Visit the game website here

SKU: ZEST1202
Normaler Preis €3.160,85 EUR exc. VAT
Normaler Preis exc. VAT Verkaufspreis €3.160,85 EUR exc. VAT
ZeST - Immuno-oncology Game

 

  • Benefits for Organisations

    🎯 Boost engagement & learning — ZeST games encourage group discussion and peer-to-peer learning.
    📈 Scalable training solution — perfect for onboarding, CPD, clinical education, leadership development and more. 
    🤝 Collaborative experiences — games are designed to involve teams actively, not just players passively.

  • What’s Included

    • All current and future ZeST online team games during the licence period.

    • Use across all teams and departments in your organisation.

    • Unlimited game sessions and participants.

    • Browser-based access — no installation required.

    • Flexible use in online meetings or face-to-face group training.

  • Contents

    Question cards

    8

    Fact cards

    4

    Treatment chart

    1

    Test result

    1